GH / IGF-1
HGH / somatropin
Mechanism not verified by source image · Peptide
Evidence at a glance
Each record keeps its own evidence class. Counts are records in this public edition, not a quality score.
Open in the interactive library →Compare with other compounds →
Records (1)
H
Human clinical / research
Human clinical / research
Genotropin adult GH deficiency label
Administration reported for this specific study or labeled indication.
Context: Adults with growth hormone deficiency
Approved product label: Amount: Approximately 0.2 mg/day for the non-weight-based starting approach; Route: Subcutaneous; Frequency: Daily; Species: Human; Population: Adults with growth hormone deficiency
Limitations: The label also describes a weight-based approach. The non-weight-based dose is individualized over time.
Route: Subcutaneous
Open this exact record in the library →Suggest a correction
CONTINUE THE RESEARCH
Follow the pathway.
These compounds share an Atlas pathway label. That is a navigation connection, not evidence of equivalent effects or suitability together.
Browse this pathway in the library →
Educational research summary. Study amounts are research context, not a dose recommendation. Not medical advice.